Mainz Biomed N.V. (NASDAQ: QUCY) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MAINZ BIOMED N.V.

Mainz Biomed N.V. (NASDAQ: QUCY)
Listen to this Section

$1.49
+0.0150 ( +1.02% ) 788.2K

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Market Data
Open $1.49
Previous Close $1.47
Volume 788.2K
Market Cap $33.47M
Day Range $1.42 - $1.56
52 Week Range $0.30 - $4.93
Shares Outstanding 22.77M
Change % +1.02%
Net Change ▲ 0.0150
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2021
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings

No data available for selected period.

Latest News

About US

Services

Stay Connected